Cannell & Spears’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.78M | Sell |
84,151
-113
| -0.1% | -$11.8K | 0.18% | 103 |
|
|
2025
Q1 | $9.83M | Buy |
84,264
+2,177
| +3% | +$254K | 0.21% | 99 |
|
|
2024
Q4 | $6.95M | Hold |
82,087
| – | – | 0.14% | 114 |
|
|
2024
Q3 | $7.38M | Sell |
82,087
-5
| -0% | -$449 | 0.15% | 114 |
|
|
2024
Q2 | $6.61M | Sell |
82,092
-638
| -0.8% | -$51.4K | 0.14% | 112 |
|
|
2024
Q1 | $6.6M | Buy |
+82,730
| New | +$6.6M | 0.14% | 117 |
|